All Flu

Manufacturer: The Wellness Center For Research and Education | Apotheca Company
Effective date: 2025-05-30
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: legacy-cache
Hydrated at: 2026-08-01 20:37:26

Label at a glance#

ProductAll Flu

Active ingredientACONITUM NAPELLUS, ARSENIC TRIIODIDE, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, ESCARGOT SHELL, COOKED, HYDROGEN, INFLUENZA A VIRUS, INFLUENZA B VIRUS, WOOD CREOSOTE, PHOSPHORUS, TEUCRIUM SCORODONIA FLOWERING TOP, THUJA OCCIDENTALIS LEAFY TWIG, VERATRUM VIRIDE ROOT, CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE

Label structure9 sections

Dosage and administration

Adults take one capful (5 pellets) and children 2 years and over take 4 pellets: Dissolve pellets in mouth. Adults every two hours; Children every 3 to 6 hours~up to 4 times per day. Take 20 minutes before or after food or liquid. Children under 2 years, consult your health care professional before use.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS:

OTC - ACTIVE INGREDIENT SECTION

Aconitum Napellus 30C, Arsenicum Iodatum 30C, Bryonia (Alba) 30C, Eupatorium Perfoliatum 30C, Gelsemium Sempervirens 30C, Helix Tosta 30C, Hydrogen 30C, Influenzinum 30C, Kreosotum 30C, Phosphorus 30C, Teucrium Scorodonia 30C, Thuja Occidentalis 30C, Veratrum Viride 30C, Anas Barbariae, Hepatis Et Cordis Extractum 200C.

INDICATIONS:

OTC - PURPOSE SECTION

Fever, chills, cough, headache and may reduce the duration and severity of ALL FLU symptoms.

WARNINGS:

WARNINGS SECTION

If you are pregnant, may become pregnant or breastfeeding, consult your health care professional before using this product.

Stop use and consult your physician if symptoms persist for more than 3 days or worsen.

Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use if tamper evident seal is broken or missing.

KEEP OUT OF THE REACH OF CHILDREN:

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

Adults take one capful (5 pellets) and children 2 years and over take 4 pellets:

Dissolve pellets in mouth. Adults every two hours; Children every 3 to 6 hours~up to 4 times per day.

Take 20 minutes before or after food or liquid.

Children under 2 years, consult your health care professional before use.

INDICATIONS:

INDICATIONS & USAGE SECTION

Fever, chills, cough, headache and may reduce the duration and severity of ALL FLU symptoms.

INACTIVE INGREDIENTS:

INACTIVE INGREDIENT SECTION

Lactose (milk), Sucrose

QUESTIONS:

OTC - QUESTIONS SECTION

Manufactured for:

The Wellness Center for Research and Education, Inc.,

1237 S. Victoria, Oxnard, CA 93035

PACKAGE LABEL DISPLAY:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC # 50181-0044-1 HOMEOPATHIC

DR. DALE'S REMEDY

WELLNESS CENTER

ALL FLU

HOMEOPATHIC

Flu Remedy

NON TOXIC Net Wt. .88 oz (25g) (565 pellets) NO KNOWN CONTRADICTIONS

All Flu

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50181-0054-1	2025-05-30	C162847	48780-1	9d75b9d1-28d1-f424-e053-dadaa90a57ce	DRUG FACTS:
50181-0054-1	2020-01-31	C162847	48780-1	9d75b9d1-28d1-f424-e053-dadaa90a57ce	DRUG FACTS:

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ACONITUM NAPELLUS	ACTIVE INGREDIENT	U0NQ8555JD	1
ARSENIC TRIIODIDE	ACTIVE INGREDIENT	3029988O2T	1
BRYONIA ALBA ROOT	ACTIVE INGREDIENT	T7J046YI2B	1
CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	ACTIVE INGREDIENT	RN2HC612GY	1
ESCARGOT SHELL, COOKED	ACTIVE INGREDIENT	0H4593GXGV	1
EUPATORIUM PERFOLIATUM FLOWERING TOP	ACTIVE INGREDIENT	1W0775VX6E	1
GELSEMIUM SEMPERVIRENS ROOT	ACTIVE INGREDIENT	639KR60Q1Q	1
HYDROGEN	ACTIVE INGREDIENT	7YNJ3PO35Z	1
INFLUENZA A VIRUS	ACTIVE INGREDIENT	R9HH0NDE2E	1
INFLUENZA B VIRUS	ACTIVE INGREDIENT	1314JZ2X6W	1
PHOSPHORUS	ACTIVE INGREDIENT	27YLU75U4W	1
TEUCRIUM SCORODONIA FLOWERING TOP	ACTIVE INGREDIENT	LOK3I16O7G	1
THUJA OCCIDENTALIS LEAFY TWIG	ACTIVE INGREDIENT	1NT28V9397	1
VERATRUM VIRIDE ROOT	ACTIVE INGREDIENT	197B3Q7T5Q	1
WOOD CREOSOTE	ACTIVE INGREDIENT	3JYG22FD73	1
ACONITUM NAPELLUS	ACTIVE MOIETY	U0NQ8555JD	1
ARSENIC CATION (3+)	ACTIVE MOIETY	C96613F5AV	1
BRYONIA ALBA ROOT	ACTIVE MOIETY	T7J046YI2B	1
CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	ACTIVE MOIETY	RN2HC612GY	1
ESCARGOT SHELL, COOKED	ACTIVE MOIETY	0H4593GXGV	1
EUPATORIUM PERFOLIATUM FLOWERING TOP	ACTIVE MOIETY	1W0775VX6E	1
GELSEMIUM SEMPERVIRENS ROOT	ACTIVE MOIETY	639KR60Q1Q	1
HYDROGEN	ACTIVE MOIETY	7YNJ3PO35Z	1
INFLUENZA A VIRUS	ACTIVE MOIETY	R9HH0NDE2E	1
INFLUENZA B VIRUS	ACTIVE MOIETY	1314JZ2X6W	1
PHOSPHORUS	ACTIVE MOIETY	27YLU75U4W	1
TEUCRIUM SCORODONIA FLOWERING TOP	ACTIVE MOIETY	LOK3I16O7G	1
THUJA OCCIDENTALIS LEAFY TWIG	ACTIVE MOIETY	1NT28V9397	1
VERATRUM VIRIDE ROOT	ACTIVE MOIETY	197B3Q7T5Q	1
WOOD CREOSOTE	ACTIVE MOIETY	3JYG22FD73	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

All Flu
Aconitum Napellus, Arsenicum Iodatum, Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Helix Tosta, Hydrogen, Influenzinum, Kreosotum, Phosphorus, Teucrium Scorodonia, Thuja Occidentalis, Veratrum Viride, Anas Barbariae, Hepatis Et Cordis Extractum
ACONITUM NAPELLUS
ARSENIC TRIIODIDE
ARSENIC CATION (3+)
BRYONIA ALBA ROOT
EUPATORIUM PERFOLIATUM FLOWERING TOP
GELSEMIUM SEMPERVIRENS ROOT
ESCARGOT SHELL, COOKED
HYDROGEN
INFLUENZA A VIRUS
INFLUENZA B VIRUS
WOOD CREOSOTE
PHOSPHORUS
TEUCRIUM SCORODONIA FLOWERING TOP
THUJA OCCIDENTALIS LEAFY TWIG
VERATRUM VIRIDE ROOT
CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE
LACTOSE
SUCROSE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
50181-0054	50181-0054-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ACONITUM NAPELLUS	U0NQ8555JD	ACTIB
ARSENIC TRIIODIDE	3029988O2T	ACTIB
BRYONIA ALBA ROOT	T7J046YI2B	ACTIB
EUPATORIUM PERFOLIATUM FLOWERING TOP	1W0775VX6E	ACTIB
GELSEMIUM SEMPERVIRENS ROOT	639KR60Q1Q	ACTIB
ESCARGOT SHELL, COOKED	0H4593GXGV	ACTIB
HYDROGEN	7YNJ3PO35Z	ACTIB
INFLUENZA A VIRUS	R9HH0NDE2E	ACTIB
INFLUENZA B VIRUS	1314JZ2X6W	ACTIB
WOOD CREOSOTE	3JYG22FD73	ACTIB
PHOSPHORUS	27YLU75U4W	ACTIB
TEUCRIUM SCORODONIA FLOWERING TOP	LOK3I16O7G	ACTIB
THUJA OCCIDENTALIS LEAFY TWIG	1NT28V9397	ACTIB
VERATRUM VIRIDE ROOT	197B3Q7T5Q	ACTIB
CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	RN2HC612GY	ACTIB
LACTOSE	J2B2A4N98G	IACT
SUCROSE	C151H8M554	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 84 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EXTENDED RELEASE / ORAL	400 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED PELLETS / ORAL	135.2 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / RECTAL	8 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / SUBLINGUAL		352 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, SOLUTION / INTRAVENOUS	0.45 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / RESPIRATORY (INHALATION)	44.4 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / RESPIRATORY (INHALATION)	90 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	FILM, EXTENDED RELEASE / TRANSDERMAL	675 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / VAGINAL	430 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAMUSCULAR	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CREAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / RECTAL	20 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAVENOUS	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
06367c01-ec4e-4b5e-af5d-32e58d743a6a			cd2162c5-20fa-43de-925f-76f52a374066	2025-05-30	Warnings	Exact identifier spl id: 06367c01-ec4e-4b5e-af5d-32e58d743a6a spl set id: cd2162c5-20fa-43de-925f-76f52a374066

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.